<code id='356A434D7E'></code><style id='356A434D7E'></style>
    • <acronym id='356A434D7E'></acronym>
      <center id='356A434D7E'><center id='356A434D7E'><tfoot id='356A434D7E'></tfoot></center><abbr id='356A434D7E'><dir id='356A434D7E'><tfoot id='356A434D7E'></tfoot><noframes id='356A434D7E'>

    • <optgroup id='356A434D7E'><strike id='356A434D7E'><sup id='356A434D7E'></sup></strike><code id='356A434D7E'></code></optgroup>
        1. <b id='356A434D7E'><label id='356A434D7E'><select id='356A434D7E'><dt id='356A434D7E'><span id='356A434D7E'></span></dt></select></label></b><u id='356A434D7E'></u>
          <i id='356A434D7E'><strike id='356A434D7E'><tt id='356A434D7E'><pre id='356A434D7E'></pre></tt></strike></i>

          explore

          explore

          author:entertainment    Page View:49
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          People with substance use disorder deserve online privacy
          People with substance use disorder deserve online privacy

          AdobeTheeraoframpant,unconsented,andunregulatedonlinedatacollectionmayfinallybewindingdownforconsume

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Transgender sports debate: Physicians say bans are health issue

          AnjumNaveed/APAlmosthalfofU.S.stateshavebannedorrestrictedtransyouths’accesstogender-affirmingpubert